PBYI
PBYI
NASDAQ · Biotechnology

Puma Biotechnology Inc

$7.74
-2.03 (-20.78%)
As of Nov 7, 2:11 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target -29.6% upside
Low Target $2.99
Average Target $5.45
High Target $6.80
Current Price $7.74
Current
$7.74
Target
$5.45
$2.99 $5.45 avg $6.80
Scenario Analysis
Bear Case
$2.99
-61.4%
Low target
Base Case
$5.45
-29.6%
Avg target
Bull Case
$6.80
+-12.1%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$11.50
-32.7% from high
52-Week Low
$4.58
+69.0% from low
Target vs 52W High
$5.45
-52.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%